Royce & Associates LP Grows Holdings in Quipt Home Medical Corp. (NASDAQ:QIPT)

Royce & Associates LP raised its position in shares of Quipt Home Medical Corp. (NASDAQ:QIPT) by 15.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,768,789 shares of the company’s stock after purchasing an additional 240,980 shares during the quarter. Royce & Associates LP’s holdings in Quipt Home Medical were worth $5,165,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its stake in shares of Quipt Home Medical by 25.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,829 shares of the company’s stock valued at $57,000 after buying an additional 2,640 shares in the last quarter. Hsbc Holdings PLC raised its holdings in Quipt Home Medical by 10.4% during the second quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock valued at $165,000 after acquiring an additional 4,969 shares during the period. Rhumbline Advisers lifted its position in shares of Quipt Home Medical by 21.0% in the second quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after acquiring an additional 8,541 shares in the last quarter. ProShare Advisors LLC bought a new position in shares of Quipt Home Medical in the second quarter worth about $35,000. Finally, Russell Investments Group Ltd. grew its position in shares of Quipt Home Medical by 2.4% during the first quarter. Russell Investments Group Ltd. now owns 511,348 shares of the company’s stock worth $2,235,000 after purchasing an additional 12,070 shares in the last quarter. 42.85% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on QIPT shares. Benchmark lowered their price target on Quipt Home Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a report on Wednesday, August 21st. Canaccord Genuity Group lowered their target price on shares of Quipt Home Medical from $8.00 to $6.00 and set a “buy” rating on the stock in a report on Friday, August 16th. One equities research analyst has rated the stock with a sell rating, three have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $6.25.

Quipt Home Medical Stock Performance

NASDAQ QIPT opened at $2.45 on Tuesday. The stock has a market capitalization of $105.57 million, a PE ratio of -22.27 and a beta of 0.62. Quipt Home Medical Corp. has a 1-year low of $2.44 and a 1-year high of $5.29. The business has a 50 day simple moving average of $2.76 and a two-hundred day simple moving average of $3.10. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.11 and a quick ratio of 0.77.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.